- Home
- LMAT vs USA Comparison
LMAT vs USA Comparison
Compare LMAT & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMAT
- USA
- Stock Information
- Founded
- LMAT 1983
- USA 1986
- Country
- LMAT United States
- USA United States
- Employees
- LMAT N/A
- USA N/A
- Industry
- LMAT Medical/Dental Instruments
- USA Finance Companies
- Sector
- LMAT Health Care
- USA Finance
- Exchange
- LMAT Nasdaq
- USA Nasdaq
- Market Cap
- LMAT 1.9B
- USA N/A
- IPO Year
- LMAT 2006
- USA N/A
- Fundamental
- Price
- LMAT $84.06
- USA $6.84
- Analyst Decision
- LMAT Buy
- USA
- Analyst Count
- LMAT 6
- USA 0
- Target Price
- LMAT $100.80
- USA N/A
- AVG Volume (30 Days)
- LMAT 156.3K
- USA 880.5K
- Earning Date
- LMAT 07-31-2025
- USA 01-01-0001
- Dividend Yield
- LMAT 0.95%
- USA 9.66%
- EPS Growth
- LMAT 30.45
- USA N/A
- EPS
- LMAT 1.97
- USA N/A
- Revenue
- LMAT $226,256,000.00
- USA N/A
- Revenue This Year
- LMAT $13.88
- USA N/A
- Revenue Next Year
- LMAT $8.81
- USA N/A
- P/E Ratio
- LMAT $42.77
- USA N/A
- Revenue Growth
- LMAT 13.19
- USA N/A
- 52 Week Low
- LMAT $71.42
- USA $5.62
- 52 Week High
- LMAT $109.58
- USA $7.09
- Technical
- Relative Strength Index (RSI)
- LMAT 50.08
- USA 63.59
- Support Level
- LMAT $80.86
- USA $6.64
- Resistance Level
- LMAT $83.72
- USA $6.85
- Average True Range (ATR)
- LMAT 1.97
- USA 0.07
- MACD
- LMAT 0.13
- USA 0.01
- Stochastic Oscillator
- LMAT 53.46
- USA 92.65
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.